FIELD: medicine.
SUBSTANCE: presented group of inventions relates to urology. Disclosed are methods for reducing mean obstructive voiding symptoms (MOVS) in mammals having obstructive lower urinary tract symptoms (LUTS), selected from a group consisting of strain, weak jet, interrupted jet and incomplete emptying, and benign prostatic hyperplasia (BPH). Methods include identifying mammals having BPH and the above symptoms and administering a composition containing a peptide Ile-Asp-Gln-Gln-Val-Leu-Ser-Arg-Ile-Lys-Leu-Glu-Ile-Lys-Arg-Cys-Leu (fexapotide triflutate).
EFFECT: presented group of inventions provides improvement of MOVS due to introduction of a composition containing fexapotide triflutate.
12 cl, 7 tbl, 4 ex
